PMID: 18719371Aug 23, 2008Paper

p53-Ubl fusions as models of ubiquitination, sumoylation and neddylation of p53

Cell Cycle
Stephanie Carter, Karen H Vousden

Abstract

The tumour suppressor p53 has been shown to be modified at its C-terminus with ubiquitin and the ubiquitin-like proteins SUMO and NEDD8. Whereas monoubiquitination of p53 is strongly associated with nuclear export, the effects of sumoylation and neddylation remain unclear. In this study we have generated p53-Ub, p53-SUMO-1 and p53-NEDD8 fusion proteins as models for the effect of these modifications on the localization and function of p53. As shown before, the ubiquitin fusion clearly drives nuclear export of p53 and we now find that this is also partially the case for a SUMO-1 fusion, which does not localise to PML bodies. In contrast a NEDD8 fusion has little effect on nuclear export, and mutating NEDD8 to more closely resemble ubiquitin did not restore nuclear export. Despite their differing subcellular localization, we find that both p53-ubiquitin and p53-NEDD8 retain similar transcriptional activity and both induce apoptosis at a similar level to unfused p53. The p53-ubiquitin fusion protein is potentially a good model for studying the role of p53 outside the nucleus. However, in our experiments we find that the export of p53 from the nucleus is not sufficient to activate its cytoplasmic apoptotic function which may depend...Continue Reading

Citations

Jun 23, 2009·Cell Death and Differentiation·J T Lee, W Gu
Nov 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Chao DaiWei Gu
Mar 14, 2012·The Journal of Biological Chemistry·Boxiao DingJiaoti Huang
May 12, 2010·Cold Spring Harbor Perspectives in Biology·David W Meek, Carl W Anderson
Nov 6, 2009·Journal of Virology·Chung-Hsin TsengMichael M C Lai
Oct 25, 2011·PloS One·Elisa Da Silva-FerradaValérie Lang
Feb 26, 2013·PloS One·Akshit AroraSubhash M Agarwal
Dec 12, 2012·International Journal of Molecular Sciences·Rami Abou ZeinabRoger Leng
May 21, 2013·Cellular and Molecular Life Sciences : CMLS·Nikolina VlatkovićCarlos P Rubbi
Jan 15, 2014·Antioxidants & Redox Signaling·Yongchao ZhaoYi Sun
Aug 31, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Chuck C-K Chao
Jan 15, 2013·Parasitology International·Roberta V PereiraRenata Guerra-Sá
Oct 12, 2010·Trends in Molecular Medicine·Chao Dai, Wei Gu
Sep 1, 2015·Critical Reviews in Oncology/hematology·Ting-Xun LuJian-Yong Li
Jan 31, 2009·Current Opinion in Genetics & Development·Stephanie Carter, Karen H Vousden
Dec 16, 2010·Molecular Immunology·Jihuan FuHong Tang
Aug 25, 2012·Cell Cycle·Lindsey D Mayo
Sep 9, 2011·Cell Cycle·Maren H StindtKaren H Vousden
Feb 15, 2011·Cancer Cell·Ian R WatsonMichael Ohh
Jun 8, 2013·Biochimica Et Biophysica Acta·Andreas K Hock, Karen H Vousden
Nov 25, 2016·Nature Communications·Carolina Villarroya-BeltriFrancisco Sánchez-Madrid
Oct 21, 2017·The Journal of Cell Biology·David RibetPascale Cossart
Feb 7, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maria Lauda TomasiNirmala Mavila
Jul 10, 2019·Journal of Molecular Cell Biology·Yanqing LiuWei Gu
Mar 7, 2014·Cell & Bioscience·Chenxi GaoJing Hu
Aug 3, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jing WangPierre P Massion
Jan 10, 2021·Biochemical Pharmacology·Zhifei XuPeihua Luo
Mar 7, 2021·Cancers·Mengwu Pan, Christine Blattner
Dec 19, 2015·BMC Bioinformatics·Ahmet Sinan YavuzOsman Uğur Sezerman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis